Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000169961 | SCV000226770 | likely benign | not specified | 2016-04-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000539050 | SCV000639473 | likely benign | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2024-11-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001706103 | SCV001890676 | likely benign | not provided | 2020-04-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001706103 | SCV005209114 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Centre for Population Genomics, |
RCV004724968 | SCV005335155 | benign | CDKL5 disorder | 2024-07-02 | criteria provided, single submitter | curation | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD v3 is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). |
Rett |
RCV000169961 | SCV000222262 | benign | not specified | 2014-05-15 | no assertion criteria provided | curation |